| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 674035 | 71088 | RISPERIDONA KRKA 0.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RISPERIDONA KRKA 0.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 20 comprimidos | 0,5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71088/71088_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71088/71088_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2016-02-25 | 1 | 1 | 1 | 2016-02-25 | 2016-03-29 | 1 | 2024-01-29 | View Edit Delete | ||||||||||||
| 674045 | 71089 | RISPERIDONA KRKA 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISPERIDONA KRKA 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 1 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71089/71089_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71089/71089_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2016-02-25 | 1 | 1 | 1 | 2016-02-25 | 2016-03-29 | 1 | 2018-10-02 | View Edit Delete | ||||||||||||
| 674053 | 71090 | RISPERIDONA KRKA 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RISPERIDONA KRKA 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 60 comprimidos | 2 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71090/71090_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71090/71090_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2016-02-25 | 1 | 1 | 1 | 2016-02-25 | 2016-03-29 | 1 | 2017-05-11 | View Edit Delete | ||||||||||||
| 674060 | 71091 | RISPERIDONA KRKA 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | RISPERIDONA KRKA 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 3 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71091/71091_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71091/71091_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2016-02-25 | 1 | 1 | 1 | 2016-02-25 | 2016-03-29 | 1 | 2018-10-04 | View Edit Delete | ||||||||||||
| 672294 | 68517 | NUROFEN RAPID 400 mg CAPSULAS BLANDAS | NUROFEN RAPID 400 mg CAPSULAS BLANDAS , 20 cápsulas | 400 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68517/68517_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68517/68517_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71183 | RECKITT BENCKISER HEALTHCARE S.A. | 2007-02-26 | 1 | 1 | 1 | 2007-02-26 | 2010-07-21 | 1 | 2020-12-23 | View Edit Delete | ||||||||||||
| 672025 | 70069 | SEVIKAR 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEVIKAR 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70069/70069_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70069/70069_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2008-09-16 | 1 | 1 | 1 | 2008-09-16 | 2011-05-11 | 1 | 2011-06-02 | 661486 | View Edit Delete | |||||||||||
| 672035 | 70071 | CAPENON 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON 40 mg/10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70071/70071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70071/70071_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2008-09-16 | 1 | 1 | 1 | 2008-09-16 | 2011-05-11 | 1 | 2011-10-28 | 661491 | View Edit Delete | |||||||||||
| 674878 | 72693 | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72693/72693_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72693/72693_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 674883 | 72694 | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OPENVAS PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72694/72694_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72694/72694_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 674888 | 72695 | OLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OLMETEC PLUS 40 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72695/72695_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72695/72695_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 674892 | 72697 | OLMETEC PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | OLMETEC PLUS 40 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72697/72697_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72697/72697_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2010-10-05 | 1 | 1 | 1 | 2010-10-05 | 2010-10-05 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 672418 | 72690 | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 200 ml (vidrio) | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml (vidrio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72690/72690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72690/72690_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-09-02 | 1 | 1 | 1 | 2010-09-02 | 2010-09-02 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 672419 | 72690 | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL | CINFATUSINA 3,54 mg/ml SUSPENSIÓN ORAL, 1 frasco de 120 ml (vidrio) | 3,54 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml (vidrio) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72690/72690_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72690/72690_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2010-09-02 | 1 | 1 | 1 | 2010-09-02 | 2010-09-02 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 672975 | 49417 | SENIORAL JARABE NIÑOS | SENIORAL JARABE NIÑOS, 1 frasco de 150 ml | 2,25 mg/15 ml + 19,5 mg/15 ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49417/49417_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49417/49417_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1971-07-01 | 1 | 1 | 1 | 1971-07-01 | 2011-05-16 | 1 | 2011-09-09 | 699256 | View Edit Delete | |||||||||||
| 674598 | 63535 | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL | GADOVIST 1 mmol/ml SOLUCION INYECTABLE EN VIAL , 1 vial de 65 ml | 1 mmol/ml | 6 | 1 | 34 | 1 vial de 65 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63535/63535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63535/63535_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11424 | BAYER HISPANIA S.L. | 2001-01-16 | 1 | 1 | 1 | 2001-01-16 | 2001-01-16 | 0 | 2011-10-11 | View Edit Delete | ||||||||||||
| 672220 | 61499 | PLASBUMIN 20% solución para perfusión | PLASBUMIN 20% solución para perfusión, 1 frasco de 100 ml | 200 g/L inyectable perfusión 100 ml | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61499/61499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61499/61499_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2020-05-25 | 1 | 2023-10-16 | View Edit Delete | ||||||||||||
| 672238 | 61499 | PLASBUMIN 20% solución para perfusión | PLASBUMIN 20% solución para perfusión, 1 frasco de 50 ml | 200 g/L inyectable perfusión 50 ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61499/61499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61499/61499_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2018-10-29 | View Edit Delete | ||||||||||||
| 673225 | 71098 | LATANOPROST AUROVITAS 50 microgramos/ml COLIRIO EN SOLUCION | LATANOPROST AUROVITAS 50 microgramos/ml COLIRIO EN SOLUCION , 1 frasco de 2,5 ml | 50 microgramos/ml | 6 | 2,5 | 26 | 1 frasco de 2,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71098/71098_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71098/71098_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2010-01-19 | 1 | 1 | 1 | 2010-01-19 | 2011-08-08 | 1 | 2011-09-27 | 664591, 673015 | View Edit Delete | |||||||||||
| 673046 | 61461 | NASOLINA 0,57 MG/ML SOLUCIÓN PARA PULVERIZACIÓN NASAL | NASOLINA 0,57 MG/ML SOLUCIÓN PARA PULVERIZACIÓN NASAL, 1 envase pulverizador de 20 ml | 0,5 mg/ml | 6 | 20 | 26 | 1 envase pulverizador de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61461/61461_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61461/61461_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1997-05-01 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 672680 | 72921 | EQUINACEA ARKOPHARMA cápsulas duras | EQUINACEA ARKOPHARMA cápsulas duras , 50 cápsulas | 250 mg | 6 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72921/72921_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72921/72921_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-10-22 | 1 | 1 | 1 | 2010-10-22 | 2010-10-22 | 0 | 2011-04-25 | View Edit Delete |
Page 262 of 1035, showing 20 records out of 20697 total, starting on record 5221, ending on 5240